# Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

> **NCT03109262** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 42 (actual)

## Conditions studied

- Primary Malignant Liver Neoplasm

## Interventions

- **PROCEDURE:** Computed Tomography (CT)
- **PROCEDURE:** Positron Emission Tomography (PET)
- **DEVICE:** 90-Yttrium (Y-90) Glass Microspheres
- **DIAGNOSTIC_TEST:** Technetium 99mTc albumin aggregated (99mTc-MAA)
- **PROCEDURE:** Single-photon emission computerized tomography (SPECT) scan

## Key facts

- **NCT ID:** NCT03109262
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2019-05-30
- **Final completion:** 2021-02-28
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03109262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03109262, "Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03109262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*